Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain.
Kaasa
Stein
S
Department of Cancer Research and Molecular Medicine, Medical Faculty, Norwegian University of Science and Technology, Trondheim, Norway.
Moksnes
Kristin
K
Nolte
Thomas
T
Lefebvre-Kuntz
Daniele
D
Popper
Lars
L
Kress
Hans Georg
HG
D000281:Administration, Intranasal; D000328:Adult; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000150:complications*; D010146:Pain / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D012189:Retrospective Studies; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D005283:Fentanyl